Related references
Note: Only part of the references are listed.Candida auris Isolates of the Southern Asian and South African Lineages Exhibit Different Phenotypic and Antifungal Susceptibility Profiles In Vitro
Adrien Szekely et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2019)
Fluconazole Resistance in Isolates of Uncommon Pathogenic Yeast Species from the United Kingdom
Andrew M. Borman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Five-Year National Surveillance of Invasive Candidiasis: Species Distribution and Azole Susceptibility from the China Hospital Invasive Fungal Surveillance Net (CHIF-NET) Study
Meng Xiao et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Are In Vitro Susceptibilities to Azole Antifungals Predictive of Clinical Outcome in the Treatment of Candidemia?
Twisha S. Patel et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2018)
Advances in the Treatment of Mycoses in Pediatric Patients
Elias Iosifidis et al.
JOURNAL OF FUNGI (2018)
Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14)
Stephane Bretagne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Establishment and Use of Epidemiological Cutoff Values for Molds and Yeasts by Use of the Clinical and Laboratory Standards Institute M57 Standard
Shawn R. Lockhart et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2017)
Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry
Luisa Duran Graeff et al.
MYCOSES (2017)
Magnusiomyces capitatus Peritonitis in a Child With Acute Lymphocytic Leukemia as a Breakthrough Infection During Caspofungin Therapy
Ayse Baris et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2017)
Comparison of EUCAST and CLSI Reference Microdilution MICs of Eight Antifungal Compounds for Candida auris and Associated Tentative Epidemiological Cutoff Values
M. C. Arendrup et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The role of epidemiological cutoff values (ECVs/ECOFFs) in antifungal susceptibility testing and interpretation for uncommon yeasts and moulds
Ana Espinel-Ingroff et al.
REVISTA IBEROAMERICANA DE MICOLOGIA (2016)
Invasive Trichosporon Infection: a Systematic Review on a Re-emerging Fungal Pathogen
Joao N. de Almeida Junior et al.
FRONTIERS IN MICROBIOLOGY (2016)
Invasive Candidiasis
Bart Jan Kullberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Uncommon Candida Species Fungemia among Cancer Patients, Houston, Texas, USA
Dong Sik Jung et al.
EMERGING INFECTIOUS DISEASES (2015)
ESCMID† and ECMM‡ joint clinical guidelines for the diagnosis and management of rare invasive yeast infections
M. C. Arendrup et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Use of Anidulafungin as a Surrogate Marker To Predict Susceptibility and Resistance to Caspofungin among 4,290 Clinical Isolates of Candida by Using CLSI Methods and Interpretive Criteria
Michael A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2014)
Molecular Identification, Antifungal Susceptibility Profile, and Biofilm Formation of Clinical and Environmental Rhodotorula Species Isolates
Jorge Meneses Nunes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Comparison of the Vitek 2 yeast susceptibility system with CLSI microdilution for antifungal susceptibility testing of fluconazole and voriconazole against Candida spp., using new clinical breakpoints and epidemiological cutoff values
Michael A. Pfaller et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Epidemiology, Antifungal Susceptibility, and Pathogenicity of Candida africana Isolates from the United Kingdom
Andrew M. Borman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance
Michael A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2013)
Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004-2008
Michael Pfaller et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2012)
Uncommon yeast infections in hematological patients: from diagnosis to treatment
Morena Caira et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2011)
Triazole and Echinocandin MIC Distributions with Epidemiological Cutoff Values for Differentiation of Wild-Type Strains from Non-Wild-Type Strains of Six Uncommon Species of Candida
Michael A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Emerging opportunistic yeast infections
Marisa H. Miceli et al.
LANCET INFECTIOUS DISEASES (2011)
Breakthrough Saprochaete capitata infections in patients receiving echinocandins: case report and review of the literature
C. Schuermans et al.
MEDICAL MYCOLOGY (2011)
Rapid Molecular Identification of Pathogenic Yeasts by Pyrosequencing Analysis of 35 Nucleotides of Internal Transcribed Spacer 2
Andrew M. Borman et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Susceptibility profile of clinical isolates of non-Cryptococcus neoformans/non-Cryptococcus gattii Cryptococcus species and literature review
Leticia Bernal-Martinez et al.
MEDICAL MYCOLOGY (2010)
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing
M. A. Pfaller et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Bloodstream Infections Due to Trichosporon spp.: Species Distribution, Trichosporon asahii Genotypes Determined on the Basis of Ribosomal DNA Intergenic Spacer 1 Sequencing, and Antifungal Susceptibility Testing
Thomas C. Chagas-Neto et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Disseminated Geotrichum candidum infection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature
T. J. Henrich et al.
TRANSPLANT INFECTIOUS DISEASE (2009)
Breakthrough Trichosporon asahii fungemia in neutropenic patient with acute leukemia while receiving caspofungin
G. Bayramoglu et al.
INFECTION (2008)
Molecular identification of unusual pathogenic yeast isolates by large ribosomal subunit gene sequencing: 2 years of experience at the United Kingdom Mycology Reference Laboratory
Christopher J. Linton et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
In vitro activities of 5-fluorocytosine against 8,803 clinical isolates of Candida spp.:: Global assessment of primary resistance using National Committee for Clinical Laboratory Standards susceptibility testing methods
MA Pfaller et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Multidrug-resistant Trichosporon asahii infection of nongranulocytopenic patients in three intensive care units
DG Wolf et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2001)
Share Paper
